FDA Inspection 1083806 — Blood Bank of Alaska, Inc.

Blood Bank of Alaska, Inc. — FEI 3071403

The FDA completed an inspection of Blood Bank of Alaska, Inc. on March 22, 2019 in Anchorage, AK. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 22, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Anchorage, AK (United States)

Citations

IDCFRDescription
23821 CFR 640.11(a)General requirements - storage
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs